Stay updated on Daratumumab Combo in Severe Renal Impairment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Severe Renal Impairment Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page-level notice about government funding and operating status was removed. No core trial content or eligibility information appears altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-16T05:52:12.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Minor layout and formatting updates to the Study Details page; core content such as eligibility criteria, outcomes, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-01T23:56:25.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    - Removed a MedlinePlus Genetics topic: Multiple myeloma. - Overall, minimal impact on core content beyond the removal of that topic; no additions or other changes.
    Difference
    0.2%
    Check dated 2025-10-18T16:06:05.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic on multiple myeloma; no deletions observed.
    Difference
    0.2%
    Check dated 2025-10-11T09:55:48.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Site updates include a status/operational notice and a version upgrade to v3.2.0, with removal of a prior related-topic entry (Multiple myeloma) and v3.1.0, signaling a page-wide refresh.
    Difference
    4%
    Check dated 2025-10-04T03:00:56.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Updated topic coverage to include MedlinePlus Genetics related topics: Multiple myeloma and the new revision v3.1.0; the older term Plasma cell myeloma and the previous revision v3.0.2 were removed, indicating a terminology update and content refresh.
    Difference
    0.5%
    Check dated 2025-09-27T02:09:30.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Severe Renal Impairment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.